Skip to main content
SpringerLink
Log in

The Diagnosis and Management of Uveitis

  • Practical Therapeutics
  • Published:
Drugs Aims and scope Submit manuscript

Summary

The diagnosis and management of uveitis is complicated and challenging. The protean signs and symptoms seen in patients with uveitis may lead to a diagnostic dilemma. A carefully taken history with particular attention to demographic factors and meticulous physical examination are crucial to guiding diagnostic testing. Tailoring the diagnostic approach in patients with uveitis frequently yields useful data in contrast to blanketing every possible uveitic entity. It is also important to distinguish among various aetiologies, including infectious and neoplastic causes which may respond to specific therapy.

Medical treatment of noninfectious uveitis must have clear objectives including reduction of inflammation, relief of symptoms and restoration of visual functioning. Familiarity with possible symptoms and signs of adverse drug reactions is essential early in the course of treatment so that their effects may be minimised. Appropriate therapy of presumed autoimmune uveitis is based on disease severity, presence or absence of bilateral disease and the health status of the patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Henderly DE, Haymind RS, Rao NA, et al. The significance of pars plana exudate in pars planitis. Am J Ophthalmol 1987; 103: 669–71.

    PubMed  CAS  Google Scholar 

  2. Smith RE, Godfrey WA, Kimura SJ. Chronic cyclitis. Course and visual prognosis. Trans Am Acad Ophthalmol Otolaryngol 1973; 77: 760–8.

    Google Scholar 

  3. Ferris FL III, Kassiff A, Bresnick GH, et al. New visual acuity charts for clinical research. Am J Ophthalmol 1982; 94: 91–6.

    PubMed  Google Scholar 

  4. Hakin KN, Watson PG. Systemic associations of scleritis. Int Ophthalmol Clin 1991; 31: 111–29.

    Article  PubMed  CAS  Google Scholar 

  5. Pouliquen Y, Haye C, Bisson J, et al. Ultrastructure de la keratopathie en bandelette. Arch Ophthal (Paris) 1967; 27: 149.

    CAS  Google Scholar 

  6. o’Connor GR. Calcific band keratopathy. Trans Am Opthalmol Soc 1972; 70: 58.

    Google Scholar 

  7. Nussenblatt RB, Palestine AG. Uveitis: fundamentals and clinical practice. Chicago: Year Book Medical Publishers, 1989.

    Google Scholar 

  8. Smith RE, Nozik NE. Uveitis: a clinical approach to diagnosis and management. Baltimore: Williams and Wilkins, 1989.

    Google Scholar 

  9. Rosenbaum JT. Systemic associations of anterior uveitis. Int Ophthalmol Clin 1991; 31: 131–42.

    Article  PubMed  CAS  Google Scholar 

  10. Hogan MJ, Kimura SJ, Thygeson P. Signs and symptoms of uveitis: I. anterior uveitis. Am J Ophthalmol 1959; 47: 155–70.

    PubMed  CAS  Google Scholar 

  11. Schlaegel Jr TF. Essentials of uveitis. Boston: Little, Brown & Co., 1969.

    Google Scholar 

  12. Whitcup SM, Nussenblatt RN, de Smet MD, et al. The diagnosis and management of severe uveitis. Annual Meeting, American Academy of Ophthalmology. Chicago: Amercian Academy of Ophthalmology, 1993.

    Google Scholar 

  13. Oski FA, DeAngelis CD, Feigin RD, et al. Principles and practice of pediatrics. Philadelphia: Lippincott, 1990.

    Google Scholar 

  14. Uhlenhuth PT. Zur Lehre von der Unterscheidung verschiedener Eiweissarten mit Hilfe spezifixher Sera, in Fetschrift zum 60 Gerburstag von Robert Koch. Jena: Fischer, 1903: 49–74.

    Google Scholar 

  15. Wacker WB, Lipton MM. Experimental allergic uveitis: homologous retina as uveitogenic antigen. Nature 1965; 206: 253–8.

    Article  PubMed  CAS  Google Scholar 

  16. Wacker WB, Kaslow CM, Yankeelov JA, et al. Experimental allergic uveitis. Isolation, characterization, and localization of a soluble uveitogenic antigen from bovine retina. J Immunol 1977; 119: 1949–58.

    PubMed  CAS  Google Scholar 

  17. Caspi RR, Roberge FG, Chan CC, et al. New model of autoimmune disease: experimental uveoretinitis induced in mice with two different retinal antigens. J Immunol 1988; 140: 1490–5.

    PubMed  CAS  Google Scholar 

  18. Marak Jr GE. Recent Advances in sympathetic ophthalmia. Surv Ophthalmol 1979; 24: 141–56.

    Article  PubMed  Google Scholar 

  19. Chan CC, Palestine AG, Nussenblatt RB. Antiretinal Antibodies in Vogt-Koyanagi-Harada syndrome, Behçet’s disease, and sympathetic ophthalmia. Ophthalmology 1985; 92: 1025–98.

    PubMed  CAS  Google Scholar 

  20. Chan CC, Ben Ezra D, Hsu SM. Granulomas in sympathetic ophthalmia and sarcoidosis: immunohistochemical study. Arch Ophthalmol 1985; 103: 198–202.

    Article  PubMed  CAS  Google Scholar 

  21. Chan CC, Ben Ezra D, Rodrigues MM, et al. Immunohistochemistry and electron microscopy of choroidal infiltrates and Dalen-Fuchs nodules in sympathetic ophthalmia. Ophthalmology 1985; 92: 580–90.

    PubMed  CAS  Google Scholar 

  22. Momoeda S. Lymphocyte transformation test in Vogt-Koyanagi-Harada syndrome. Nippon Ganka Gakkai Zasshi 1976; 80: 491–6.

    PubMed  CAS  Google Scholar 

  23. Maezawa H, Yano A, Taniguchi M, et al. The role of cytotoxic T lymphocytes in the pathogenesis of Vogt-Koyanagi-Harada disease. Ophthalmologica 1982; 185: 179–86.

    Article  PubMed  CAS  Google Scholar 

  24. Nussenblatt RB, Gery I, Ballentine EJ, et al. Cellular immune responsiveness of uveitis patients to retinal S-antigen. Am J Ophthalmol 1980; 89: 173–9.

    PubMed  CAS  Google Scholar 

  25. Forrester JV. Duke-Elder lecture: new concepts on the role of autoimmunity in the pathogenesis of uveitis. Eye 1992; 6: 433–46.

    Article  PubMed  Google Scholar 

  26. Deschennes J, Char DH, Kaliter S. Activated T lymphocytes in uveitis. Br J Ophthalmol 1988; 72: 83–7.

    Article  Google Scholar 

  27. Dick A, Cheng AT, Purdie JM, et al. Immunocytochemical analysis of blood lymphocytes in uveitis. Eye 1992; 6: 643–7.

    Article  PubMed  Google Scholar 

  28. Fauci AS. Clinical aspects of immunosuppression: use of cytotoxic agents and corticosteroids. In: Ballanti JA, editor. Immunology II. Philadelphia: WB Saunders, 1978.

    Google Scholar 

  29. Gilman AG, Goodman LS, Rall TW, et al. The pharmacological basis of therapeutics. New York: Macmillan, 1985.

    Google Scholar 

  30. Elkington JR, Hunt Jr AD, Godfrey L. Effects of pituitary adrenocorticotropic hormone (ACTH) therapy. JAMA 1949; 141: 1273–9.

    Article  Google Scholar 

  31. Gordon DM, McLean JM. Effects of pituitary adrenocorticotropic hormone (ACTH) therapy in ophthalmologic conditions. JAMA 1950; 142: 1271–5.

    Article  Google Scholar 

  32. Olson JA, Steffensen EH, Margulis RW, et al. Effect of ACTH on certain inflammatory diseases of the eye. JAMA 1950; 142: 1276–81.

    Article  Google Scholar 

  33. Gordon DM. Hydrocortisone in Ophthalmology. Am J Ophthalmol 1954; 37: 533–8.

    PubMed  CAS  Google Scholar 

  34. Gordon DM. Prednisone and prednisolone in ocular disease. Am J Ophthalmol 1956; 41: 593–600.

    PubMed  CAS  Google Scholar 

  35. Cook C, MacDonald RK. Effect of cortisone on the permeability of the blood-aqueous barrier to fluorescein. Br J Ophthalmol 1951; 35: 730–40.

    Article  PubMed  CAS  Google Scholar 

  36. Leibowitz HM, Kupferman A. Bioavailability and therapeutic effectiveness of topically administered corticosteroids. Trans Am Acad Ophthalmol Otolaryngol 1975; 79: 0P–78.

    Google Scholar 

  37. McCartney HJ, Drysdale IO, Gornall A, et al. An autoradiographic study of the penetration of subconjunctivally injected hydrocortisone into normal and inflammed eyes. Invest Ophthalmol 1965; 4: 297–301.

    PubMed  CAS  Google Scholar 

  38. Freeman WR, Green RL, Smith RE. Ecographic localization of corticosteroids after periocular injection. Am J Ophthalmol 1987; 103: 281–8.

    PubMed  CAS  Google Scholar 

  39. Beck RW, Cleary PA, Anderson Jr MM, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 1992; 326: 581–8.

    Article  PubMed  CAS  Google Scholar 

  40. Corley CC, Lessner SE, Larsen WE. Azathioprine therapy of “autoimmune” diseases. Am J Med 1966; 41: 404–12.

    Article  PubMed  Google Scholar 

  41. Newell FW, Krill AE. Treatment of uveitis with azathioprine imuran. Trans Ophthalmol Soc 1967; 87: 499–511.

    CAS  Google Scholar 

  42. Andrasch RH, Pirofsky B, Burns RP. Immunosuppressive therapy for severe chronic uveitis. Arch Ophthalmol 1978; 96: 241–51.

    Article  Google Scholar 

  43. Yazici H, Parzili H, Barnes CG, et al. A controlled trial of azathioprine in Behçet’s syndrome. N Engl J Med 1990; 322: 281–5.

    Article  PubMed  CAS  Google Scholar 

  44. Urowitz MB, Hunter T, Bookman AAM, et al. Azathioprine in rheumatoid arthritis: a double-blind study comparing full dose to half dose. J Rheumatol 1974; 1: 274–81.

    Google Scholar 

  45. Woodland J, Chaput-de-Saintonge DM, Evans SJ, et al. Azathioprine in rheumatoid arthritis: double-blind study of full versus half doses versus placebo. Ann Rheum Dis 1981; 40: 355–9.

    Article  PubMed  CAS  Google Scholar 

  46. Jolivet J, Cowan KH, Curt GA, et al. The pharmacology and clinical use of methotrexate. N Engl J Med 1983; 309: 1094–104.

    Article  PubMed  CAS  Google Scholar 

  47. Mitchell MS, Wade ME, DeConti RC, et al. Immunosuppressive effects of cytosine arabinoside and methotrexate in man. Ann Intern Med 1969; 70: 535–47.

    PubMed  CAS  Google Scholar 

  48. Rothenberg SP, Iqbal MP, da Costa M. Effect of folate compounds on the accumulation of methotrexate and the activity of dihydrofolate reductase in liver, kidney, and small of the mouse. J Pharmacol Exp Ther 1982; 223: 631–4.

    PubMed  CAS  Google Scholar 

  49. Wong VG, Hersh EM. Methotrexate in the therapy of cyclitis. Trans Am Acad Ophthalmol Otolaryngol 1965; 69: 279–93.

    Google Scholar 

  50. Lazar M, Weiner MJ, Leopold IH. Treatment of uveitis with methotrexate. Am J Ophthalmol 1969; 67: 383–7.

    PubMed  CAS  Google Scholar 

  51. Shah SS, Lowder C, Schmitt MA, et al. Low-dose methotrexate therapy for ocular inflammatory disease. Ophthalmology 1992; 99: 1419–23.

    PubMed  CAS  Google Scholar 

  52. Fauci AS, Haynes BF, Katz P, et al. Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 76–84.

    PubMed  CAS  Google Scholar 

  53. Hoffman GS, Kerr RY, Leavitt CW, et al. Wegener’s granulamotosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488–98.

    PubMed  CAS  Google Scholar 

  54. Oniki S, Kurakazu K, Kawata K. Immunosuppressive therapy of Behçet’s disease with cyclophosphamide. Jpn J Ophthalmol 1976; 20: 32–40.

    Google Scholar 

  55. Buckley CE III, Gills JP. Cyclophosphamide therapy of peripheral uveitis. Arch Intern Med 1969; 124: 29–35.

    Article  PubMed  Google Scholar 

  56. o’Duffy JDD, Robertson DM, Goldstein NP. Chlorambucil in the treatment of uveitis and meningoencephalitis of Behçet’s disease. Am J Med 1984; 76: 75–84.

    Article  PubMed  Google Scholar 

  57. Godfrey WA, Epstein WV, o’Connor GR, et al. The use of chlorambucil in intractable idiopathic uveitis. Am J Ophthalmol 1974; 78: 415–28.

    PubMed  CAS  Google Scholar 

  58. Tricoulis D. Treatment of Behçet’s disease with chlorambucil. Br J Ophthalmol 1976; 60: 55–7.

    Article  PubMed  CAS  Google Scholar 

  59. Jennings T, Tessler HH. Twenty cases of sympathetic ophthalmia. Br J Ophthalmol 1989; 73: 140–5.

    Article  PubMed  CAS  Google Scholar 

  60. Nussenblatt RB, Palestine AG, Chan CC. Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol 1983; 96: 275–82.

    PubMed  CAS  Google Scholar 

  61. Nussenblatt RB, Palestine AG, Rook AH, et al. Treatment of intraocular inflammatory disease with cyclosporine A. Lancet 1983; 2: 235–8.

    Article  PubMed  CAS  Google Scholar 

  62. Masuda K, Nakajima A. A double-masked study of cyclosporine in Behçet’s diseases. In: Schiinder R, editor. Cyclosporine treatment in Behçet’s disease. Berlin: Springer Verlag, 1985: 162–4.

    Google Scholar 

  63. Palestine AG, Austin HA, Balow JE, et al. Renal histopathological alterations in patients treated with cyclosporin for uveitis. N Engl J Med 1986; 314: 1293–8.

    Article  PubMed  CAS  Google Scholar 

  64. Diaz-Llopis M, Cervera M, Meneto JL. Cyclosporin therapy of Behçet’s disease: a long term study. Curr Eye Res 1990; 9 Suppl.: 17–23.

    Article  PubMed  Google Scholar 

  65. Towler HM A, Whiting PH, Forrester JV. Combination low dose cyclosporin A and steroid therapy in chronic intraocular inflammation. Eye 1990; 4: 514–20.

    Article  PubMed  Google Scholar 

  66. Bielory L, Holland C, Gascon P, et al. Uveitis, cutaneous, and neurosarcoid: treatment with low dose cyclosporin A. Transplant Proc 1988; 20 (Suppl. 4): 144–8.

    PubMed  CAS  Google Scholar 

  67. Goto T, Kino T, Hatanaka H, et al. FK 506: historical perspectives. Transplant Proc 1991; 23: 2713–7.

    PubMed  CAS  Google Scholar 

  68. Mochizuki M, Masuda K, Sakane T, et al. A multicenter clinical open trial of FK 506 in refractory uveitis including Behçet’s disease. Transplant Proc 1991; 23: 3343–6.

    PubMed  CAS  Google Scholar 

  69. Dumont RJ, Staruch MF, Koprak SL, et al. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK 506 and rapamycin. J Immunol 1990; 144: 251–8.

    PubMed  CAS  Google Scholar 

  70. Whiting PH, Woo J, Adam BJ, et al. Toxicity of rapamycin-a comparative and combination study with cyclosporine at immunotherapeutic dosage in the rat. Transplantation 1991; 52: 203–8.

    Article  PubMed  CAS  Google Scholar 

  71. Roberge FG, Chen H, Chan CC, et al. Rapamycin treatment of autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 1992; 33: 933.

    Google Scholar 

  72. Eugui EM, Almquist SJ, Muller CD, et al. Lymphocyte-selective cytostatic and Immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion. Scand J Immunol 1991; 33: 161–74.

    Article  PubMed  CAS  Google Scholar 

  73. Gery I, Allison AC, Miller-Rivero N, et al. Inhibition of experimental autoimmune uveoretinitis (EAU) by mycophenolate mofetil (MM). Invest Ophthalmol Vis Sci 1993; 34: 1480.

    Google Scholar 

  74. Wells H. Studies of the chemistry of anaphyIaxis. III. Experiments with isolated proteins, especially those of hen’s egg. J Infect Dis 1911; 9: 147–71.

    Article  CAS  Google Scholar 

  75. Bitar DM, Whitacre CC. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. Cell Immunol 1988; 112: 364–70.

    Article  PubMed  CAS  Google Scholar 

  76. Nussenblatt RB, Caspi RR, Mahdi R, et al. Inhibition of Santigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol 1990; 144: 1689–95.

    PubMed  CAS  Google Scholar 

  77. Thurau SR, Chan CC, Suh E, et al. Induction of oral tolerance to S-Ag induced experimental autoimmune uveitis by a uveitogenic 20mer peptide. J Autoimmun 1991; 4: 507–16.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Immunology, National Eye Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland, 20892, USA

    Eddy Anglade (Senior Staff Fellow) & Scott M. Whitcup

Authors
  1. Eddy Anglade
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Scott M. Whitcup
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anglade, E., Whitcup, S.M. The Diagnosis and Management of Uveitis. Drugs 49, 213–223 (1995). https://doi.org/10.2165/00003495-199549020-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199549020-00006

Keywords

Search

Navigation